REG-EVRAZ plc EVRAZ plc announces that the Appointment and the Amendments adopted as part of the Consent Solicitation for its outstanding notes due 2023 have become effective
============
EVRAZ plc (EVR)
EVRAZ plc announces that the Appointment and the Amendments adopted as
part of the Consent Solicitation for its outstanding notes due 2023 have
become effective
19-Dec-2022 / 14:00 MSK
Dissemination of a Regulatory Announcement, transmitted by EQS Group.
The issuer is solely responsible for the content of this announcement.
══════════════════════════════════════════════════════════════════════════
NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION IN OR INTO, OR TO ANY PERSON
LOCATED OR RESIDENT IN, ANY JURISDICTION WHERE IT IS UNLAWFUL TO RELEASE,
PUBLISH OR DISTRIBUTE THIS ANNOUNCEMENT OR THE CONSENT SOLICITATION
MEMORANDUM.
EVRAZ plc announces that the Appointment and the Amendments adopted as
part of the Consent Solicitation for its outstanding U.S.$750,000,000
5.375 per cent. notes due 2023 have become effective
London, 19 December 2022 – on 15 November 2022, EVRAZ plc (the “Issuer”)
announced a consent solicitation in relation to the outstanding
U.S.$750,000,000 5.375 per cent. notes due 2023 issued by the Issuer
(Regulation S Notes: Common Code 153391572 / ISIN XS1533915721; Rule 144A
Notes: Common Code 111731110 / ISIN US30050AAG85 / CUSIP 30050AAG8) (the
“Notes”) on the terms and subject to the conditions set forth in the
consent solicitation memorandum dated 15 November 2022 (the “Consent
Solicitation Memorandum”). Capitalised terms used, but not defined herein,
shall have the meanings given to them in the Consent Solicitation
Memorandum.
The Issuer notifies that, on 19 December 2022, (i) the Issuer and the New
Trustee entered into the Deed of Appointment to effectuate the
Appointment; and (ii) the Issuer and the New Trustee entered into the
Supplemental Trust Deed to effectuate the Amendments. Accordingly, the
Appointment and the Amendments have become effective and binding on all
Noteholders with effect from that date.
The Issuer extends its gratitude for the support and cooperation
demonstrated by investors which has been reflected in the successful
results of the Consent Solicitation.
Questions and requests for assistance in connection with the Consent
Solicitation should be directed to the Information and Tabulation Agent:
Limited liability company “Legal Capital Investor Services”
Address: 10 Krivokolenny lane, bldg. 6, Moscow 101000, Russia
Email: 1 evraz@lcpis.ru
Phone: +7 495 122 05 17
Website: 2 www.lcpis.ru
###
For further information:
Investor Relations
+7 495 232 1370
ir@evraz.com
══════════════════════════════════════════════════════════════════════════
ISIN: GB00B71N6K86, XS1533915721, XS1843443273,
Category Code: MSCM
TIDM: EVR
LEI Code: 5493005B7DAN39RXLK23
OAM Categories: 3.1. Additional regulated information required to be
disclosed under the laws of a Member State
Sequence No.: 209693
EQS News ID: 1516489
End of Announcement EQS News Service
══════════════════════════════════════════════════════════════════════════
3 fncls.ssp?fn=show_t_gif&application_id=1516489&application_name=news&site_id=refinitiv2
References
Visible links
1. mailto:evraz@lcpis.ru
2. https://eqs-cockpit.com/cgi-bin/fncls.ssp?fn=redirect&url=aca9a1d187ca3d886cab87c02982d6e3&application_id=1516489&site_id=refinitiv2&application_name=news
============